Genknowme (GKM) is a precision health company advancing epigenetics to deliver insights that support personalized and preventive care.
Genknowme has raised $630K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2025.
Genknowme's investors include Venture Kick, Innovaud, Foundation for Innovation and Technology (FIT).
Genknowme is headquartered in Lausanne, Switzerland.
Genknowme (GKM) is a precision health company advancing epigenetics to deliver insights that support personalized and preventive care.
Genknowme is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genknowme — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/genknowme. Accessed September 14, 2026.
VCBacked. (2025). Genknowme — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/genknowme
{{cite web |title=Genknowme — Funding & Investors |url=https://www.vcbacked.co/company/genknowme |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated